Literature DB >> 6186687

Detection of fungemia obscured by concomitant bacteremia: in vitro and in vivo studies.

L J Hockey, N K Fujita, T R Gibson, D Rotrosen, J Z Montgomerie, J E Edwards.   

Abstract

Our recent clinical experience suggested that bacteremia may interfere with the detection of concomitant fungemia when standard blood culture methods are used. To determine the extent to which bacteria may interfere with fungal isolation from blood cultures, an in vitro model simulating blood cultures taken during concomitant fungemia and bacteremia was created. Each of six bacteria (Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus faecalis, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa) was combined with each of three pathogenic yeasts (Candida albicans, Candida tropicalis, and Torulopsis glabrata) in vented blood culture bottles containing enriched brain heart infusion broth and fresh normal human blood. Blood culture bottles were analyzed at 1, 2, and 7 days of incubation. Gram strains and subcultures onto chocolate and MacConkey agars failed to detect fungi in 37.0, 66.7, and 100% of samples, respectively. However, subcultures onto Sabouraud dextrose agar failed in only 13% of the samples (occurring only with P. aeruginosa). In a rabbit model of concomitant fungemia with C. albicans and bacteremia with P. aeruginosa, no yeasts were recovered from blood cultures despite 100% detection of P. aeruginosa. Therefore, the usual microbiological techniques may be inadequate to detect fungemia when concomitant bacteremia is present.

Entities:  

Mesh:

Year:  1982        PMID: 6186687      PMCID: PMC272543          DOI: 10.1128/jcm.16.6.1080-1085.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases.

Authors:  C Singer; M H Kaplan; D Armstrong
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

2.  Hospital-acquired fungemia. Its natural course and clinical significance.

Authors:  J J Klein; C Watanakunakorn
Journal:  Am J Med       Date:  1979-07       Impact factor: 4.965

3.  Study of some factors influencing the growth of Candida albicans in vitro.

Authors:  P Auger; J Joly
Journal:  Mykosen       Date:  1978-03

4.  Fungemia with compromised host resistance. A study of 70 cases.

Authors:  R C Young; J E Bennett; G W Geelhoed; A S Levine
Journal:  Ann Intern Med       Date:  1974-05       Impact factor: 25.391

5.  Fungal infections complicating acute leukemia.

Authors:  G P Bodey
Journal:  J Chronic Dis       Date:  1966-06

6.  Increased in vitro sensitivity of Candida albicans to amphotericin B when grown in mixed culture with Escherichia coli.

Authors:  L G Mathieu; D Dube; M Lebrun
Journal:  Can J Microbiol       Date:  1978-12       Impact factor: 2.419

Review 7.  Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy.

Authors:  J E Edwards; R I Lehrer; E R Stiehm; T J Fischer; L S Young
Journal:  Ann Intern Med       Date:  1978-07       Impact factor: 25.391

Review 8.  Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients.

Authors:  B E Kreger; D E Craven; P C Carling; W R McCabe
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

9.  Hematogenous candida endophthalmitis in patients receiving parenteral hyperalimentation fluids.

Authors:  D K Henderson; J E Edwards; J Z Montgomerie
Journal:  J Infect Dis       Date:  1981-05       Impact factor: 5.226

  9 in total
  14 in total

Review 1.  Medically important bacterial-fungal interactions.

Authors:  Anton Y Peleg; Deborah A Hogan; Eleftherios Mylonakis
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

2.  Evaluation of the Bruker® MBT Sepsityper IVD module for the identification of polymicrobial blood cultures with MALDI-TOF MS.

Authors:  Anaïs Scohy; Audrey Noël; Anca Boeras; Laetitia Brassinne; Terry Laurent; Hector Rodriguez-Villalobos; Alexia Verroken
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-08-20       Impact factor: 3.267

3.  Controlled comparison of BacT/ALERT FAN aerobic medium and BATEC fungal blood culture medium for detection of fungemia.

Authors:  L C McDonald; M P Weinstein; J Fune; S Mirrett; L G Reimer; L B Reller
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

4.  Importance of selective media for recovery of yeasts from clinical specimens.

Authors:  P Sandven; J Lassen
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

5.  Pseudomonas aeruginosa inhibits in-vitro Candida biofilm development.

Authors:  H M H N Bandara; J Y Y Yau; R M Watt; L J Jin; L P Samaranayake
Journal:  BMC Microbiol       Date:  2010-04-25       Impact factor: 3.605

6.  Endothelial cell contraction increases Candida adherence to exposed extracellular matrix.

Authors:  S A Klotz; R D Maca
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

7.  Comparison of Mycosis IC/F and plus Aerobic/F media for diagnosis of fungemia by the bactec 9240 system.

Authors:  Marie-Hélène Meyer; Valérie Letscher-Bru; Benoît Jaulhac; Jocelyn Waller; Ermanno Candolfi
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

8.  Detection of bacterial and yeast species with the Bactec 9120 automated system with routine use of aerobic, anaerobic, and fungal media.

Authors:  Alfredo Chiarini; Angelo Palmeri; Teresa Amato; Rita Immordino; Salvatore Distefano; Anna Giammanco
Journal:  J Clin Microbiol       Date:  2008-10-15       Impact factor: 5.948

9.  Rapid detection and identification of Candida, Aspergillus, and Fusarium species in ocular samples using nested PCR.

Authors:  E E Jaeger; N M Carroll; S Choudhury; A A Dunlop; H M Towler; M M Matheson; P Adamson; N Okhravi; S Lightman
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

10.  Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections.

Authors:  S-H Kim; Y K Yoon; M J Kim; J W Sohn
Journal:  Clin Microbiol Infect       Date:  2012-06-01       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.